Trial Profile

The Evaluation of Patients With Acute Hypertension and Intracerebral Hemorrhage With Intravenous Clevidipine Treatment.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Oct 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clevidipine (Primary)
Indications Hypertension
Focus Registrational; Therapeutic Use
Acronyms ACCELERATE
Sponsors The Medicines Company

Most Recent Events

07 May 2012 Planned number of patients changed from 40 to 60 as repored by European Clinical Trials Database.
07 May 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-000230-53).
12 May 2010 Actual end date (1 Apr 2010) added as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com